• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

City of Hope National Medical Center

A rendering of the future City of Hope cancer center
Research

Cell therapy boosts survival in pancreatic cancer animal model

After helping extend the survival of mice with pancreatic cancer, a natural killer cell therapy from CytoImmune will be tested in humans this year.
Kyle LaHucik Jan 25, 2022 7:10am
Mouse

Novel 'nanosized' drug carriers tamp down HIV in the brain

Sep 27, 2021 10:05am
coronavirus test tubes

COVID-19 vaccines based on novel platforms show early promise

Dec 3, 2020 12:12pm
Nurse about to give an infusion

Virus makes solid tumors vulnerable to CAR-T attack in mice

Sep 2, 2020 2:00pm
Scorpion

Killing brain tumors with CAR-Ts built with scorpion venom

Mar 4, 2020 2:00pm
Clock

Targeting the 'clock gene' to slow triple-negative breast cancer

Feb 14, 2020 8:42am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings